TRPC6-mediated ERK1/2 phosphorylation prevents dentate granule cell degeneration via inhibiting mitochondrial elongation. (15th July 2017)

• Record Type: Journal Article
• Authors: Ko, Ah-Reum; Kang, Tae-Cheon
• Is Part Of: Neuropharmacology. Volume 121(2017)
• Page Start: 120
• Page End: 129
• Publication Date: 2017-07-15
• Subjects: DRP1 -- Epilepsy -- Mitochondria -- Protein kinase -- Protein phosphatase -- Seizure -- U0126; Atropine methylbromide (PubChem CIH: 656597) -- Isoflurane (PubChem CIH: 3763) -- LiCl (PubChem CIH: 433294) -- Pilocarpine hydrochloride (PubChem CIH: 5909) -- U0126 (PubChem CIH: 5354033) -- Urethane (PubChem CIH: 5641); Neuropsychopharmacology -- Periodicals; Autonomic Agents -- Periodicals; Neuropsychopharmacologie -- Périodiques; Neuropsychopharmacology; Periodicals; Electronic journals; 615.78
• DOI: 10.1016/j.neuropharm.2017.05.004
• Languages: English
• ISSNs: 0028-3908

Abstract

Abstract: Transient receptor potential canonical channel-6 (TRPC6) is one of Ca 2+ -permeable non-selective cation channels. In the rat hippocampus, TRPC6 expression is predominantly observed in dentate granule cells (DGC) rather than other hippocampal components. Interestingly, TRPC6 knockdown results in the massive DGC degeneration following status epilepticus (SE), although DGC is one of the resistant neuronal populations to various harmful stresses. However, the molecular events underlying the DGC degeneration induced by TRPC6 knockdown are still unclear. In the present study, TRPC6 knockdown resulted in mitochondrial elongation accompanied by reduction in dynamin-related proteins 1 (DRP1)-S616 phosphorylation. Furthermore, TRPC6 knockdown selectively decreased extracellular-signal-regulated kinase 1/2 (ERK1/2) phosphorylation. Similar to TRPC6 knockdown, ERK1/2 inhibition by U0126 evoked mitochondrial elongation with diminished DRP1-S616 phosphorylation, and facilitated SE-induced DGC degeneration independent of seizure severity. These findings indicate that TRPC6 may regulate mitochondrial dynamics via ERK1/2-mediaed DRP1 activation, which would be involved in DGC invulnerability to SE. Therefore, TRPC6 will be an interesting and important therapeutic target for neurological diseases related to impaired mitochondrial dynamics. Highlights: TRPC6 knockdown inhibited DRP1-mediated mitochondrial fission. TRPC6 knockdown decreased ERK1/2 phosphorylation. TRPC6 siRNA did not affect PKA, PKC, JNK and p38 MAPK activities. TRPC6 siRNA did not change PP1A, PP2A and PP2B activities. U0126 elongated mitochondrial length and induced DGC death following SE.